Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin A Kaskow

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Molecular Pharmaceutics|July 7, 2025
Carriers Multimerize STING Protein Fragments to Activate Type I Interferon Signaling in STING-Deficient Cancer CellsJustin A Kaskow, Paula T Hammond
Biomacromolecules|April 30, 2024
Poly(β-aminoester) Physicochemical Properties Govern the Delivery of siRNA from Electrostatically Assembled CoatingsAdam G Berger, Charles DeLorenzo, Chau Vo, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
A multivalent peptide-polymer conjugate material mimics STING to therapeutically activate innate immune signalingJustin A Kaskow, Julia Treese, Anita Gaenko, et al.
Journal of the American Society for Mass Spectrometry|September 9, 2024
Predicting Peptide Ionization Efficiencies for Electrospray Ionization Mass Spectrometry Using Machine LearningJustin A Kaskow, Eric T Hahnert, Thomas K Porter, et al.
Advanced Healthcare Materials|April 4, 2023
STING Protein-Based In Situ Vaccine Synergizes CD4<sup>+</sup> T, CD8<sup>+</sup> T, and NK Cells for Tumor EradicationYanpu He, Celestine Hong, Shengnan Huang, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2026
Engineering nanoparticle surface chemistry for antigen-presenting cell targeting improves specificity and safety of TLR3 agonist cancer immunotherapyVictoria F Gomerdinger, Cassandra Parada, Andrea Li, et al.
Materials Today. Bio|June 15, 2026
Polyelectrolyte nanoparticles enable intracellular delivery of STING protein fragments for ovarian cancer immunotherapyJustin A Kaskow, Altaf Bacchus, Victoria F Gomerdinger, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Molecular Pharmaceutics|July 7, 2025
Carriers Multimerize STING Protein Fragments to Activate Type I Interferon Signaling in STING-Deficient Cancer CellsJustin A Kaskow, Paula T Hammond
Biomacromolecules|April 30, 2024
Poly(β-aminoester) Physicochemical Properties Govern the Delivery of siRNA from Electrostatically Assembled CoatingsAdam G Berger, Charles DeLorenzo, Chau Vo, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
A multivalent peptide-polymer conjugate material mimics STING to therapeutically activate innate immune signalingJustin A Kaskow, Julia Treese, Anita Gaenko, et al.
Journal of the American Society for Mass Spectrometry|September 9, 2024
Predicting Peptide Ionization Efficiencies for Electrospray Ionization Mass Spectrometry Using Machine LearningJustin A Kaskow, Eric T Hahnert, Thomas K Porter, et al.
Advanced Healthcare Materials|April 4, 2023
STING Protein-Based In Situ Vaccine Synergizes CD4<sup>+</sup> T, CD8<sup>+</sup> T, and NK Cells for Tumor EradicationYanpu He, Celestine Hong, Shengnan Huang, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2026
Engineering nanoparticle surface chemistry for antigen-presenting cell targeting improves specificity and safety of TLR3 agonist cancer immunotherapyVictoria F Gomerdinger, Cassandra Parada, Andrea Li, et al.
Materials Today. Bio|June 15, 2026
Polyelectrolyte nanoparticles enable intracellular delivery of STING protein fragments for ovarian cancer immunotherapyJustin A Kaskow, Altaf Bacchus, Victoria F Gomerdinger, et al.
Pageof 1